Podcast by TEVA
Nordic Migraine Symposium 2019
Claim This Podcastby TEVA
10 episodes
Updated Daily
Accepts GuestsHas Sponsors
Podcast Overview
1 verified contact email on file for Nordic Migraine Symposium 2019
Pitch yourself as a guest, propose sponsorships, or reach out directly to the host.
Recent Episodes
June 19, 2020
US Anti-CGRP Guidelines and Clinical Experience With Anti-CGRP Antibodies – Andrew Blumenfeld
The United States (US) perspective on the use of anti-CGRP monoclonal antibodies mAbs was presented by Andrew Blumenfeld. He discussed the US guidelines and the rationale for them. 1. American Headache Society. Headache 2019;59:1-18. 2. Serrano D et al. Headache 2015;55:502-518. 3. Louter MA et al. Brain. 2013;136(Pt 11):3489-3496. 4. Schwedt TJ et al. J Headache Pain 2018;19:38. 5. Lanteri-Minet M et al. Pain 2005;118:319-326. 6. Rossi P et al. Headache 2005;45:561-570. 7. Buse DC et al. Headache 2019;59:306-338. 8. Spanou I et al. Headache 2019;59:1174-1186. 9. Walker CS et al. Ann Clin Transl Neurol 2016;3:309-310 10. Hay DL et al. Bri J Pharmacol 2018;175:3-17 11. Tough IR et al. Neurogastroenterol Motil 2018;30:e13454. 12. Stauffer VL et al. JAMA Neurol 2018;75:1080-1088. 13. Skljarevski V et al. Cephalalgia 2018;38:1442-1454. 14. Tepper SJ et al. Headache 2018;59:276-290. 15. Ferrari MD et al. Lancet 2019:1-11.
June 19, 2020
EHF Anti-CGRP Treatment Recommendations – Lars Bendtsen
As co-author of the European Headache Federation (EHF) guideline on the use of anti-CGRP monoclonal antibodies (mAbs) for migraine prevention, Lars Bendtsen presented an overview of the scientific basis for the recommendations. 1. Sacco et al. J Headache Pain 2019.
June 19, 2020
Acute and Preventative Treatments – Anna Sundholm
Anna Sundholm presented an overview of all currently available acute and preventative treatments for the different migraine patients, and how to use them most effectively. 1. Steiner TJ et al. J Headache Pain 2011;12:419-426. 2. Steiner TJ et al. J Headache Pain 2019;20:24. 3. Sundholm A et al. Lakartidningen 2020;117. pii: FTS7. 4. http://www.huvudvarkssallskapet.se/ Accessed December 2019. 5. Silberstein SD. CNS Spectrums 2017;22:4-12. 6. Cameron C et al. Headache 2015;55 Suppl 4:221-235. 7. Ong JJY et al. Neurotherapeutics 2015;15:274-290. 8. Lipton RB et al. JAMA 200;284:2599-2605. 9. Sculpher M et al. Pharmacoeconomics 2002;20:91-100. 10. Ferrari MD et al. Lancet 2001;358:1668-1675. 11. Freitag F et al. Headache 2008;48: 341-354. 12. Brandes JL et al. Cephalalgia 2005;25: 735-742. 13. Lipton RB et al. Headache 2017;57:1026-1040. 14. Brandes JL et al. JAMA 2007;297:1443-1454. 15. ICHD-3. Cephalalgia 2018;38:1-211. 16. Evers S et al. Eur J Neurol 2009;16:968-981. 17. Silberstein S et al. Headache 2009;49:1153-1162. 18. Aurora SK et al. Headache 2011;51:1358-1373. 19. Tepper SJ et al. Lancet Neurol 2017;16: 425-434. 20. Ruff DD et al. Cephalalgia 2019;39:931-944. 21. Ferrari MD et al. Lancet 2019;394:1030-1040. 22. Tfelt-Hansen P et al. CNS Drugs 2012;26:375-382.
10 total episodes available
Deep-dive analytics for Nordic Migraine Symposium 2019
Frequently asked questions
Have a different question and can't find the answer you're looking for? Reach out to our support team by sending us an email and we'll get back to you as soon as we can.
- What is Nordic Migraine Symposium 2019?
- How often does this podcast release new episodes?
This podcast updates daily.
- Where can I listen to this podcast?
This podcast is available on 4 platforms including Apple Podcasts, Spotify, and more. You can also use the RSS feed directly.
- Does this podcast accept guests?
Yes, this podcast regularly features guests.
Legal Disclaimer
Pod Engine is not affiliated with, endorsed by, or officially connected with any of the podcasts displayed on this platform. We operate independently as a podcast discovery and analytics service.
All podcast artwork, thumbnails, and content displayed on this page are the property of their respective owners and are protected by applicable copyright laws. This includes, but is not limited to, podcast cover art, episode artwork, show descriptions, episode titles, transcripts, audio snippets, and any other content originating from the podcast creators or their licensors.
We display this content under fair use principles and/or implied license for the purpose of podcast discovery, information, and commentary. We make no claim of ownership over any podcast content, artwork, or related materials shown on this platform. All trademarks, service marks, and trade names are the property of their respective owners.
While we strive to ensure all content usage is properly authorized, if you are a rights holder and believe your content is being used inappropriately or without proper authorization, please contact us immediately at hey@podengine.ai for prompt review and appropriate action, which may include content removal or proper attribution.
By accessing and using this platform, you acknowledge and agree to respect all applicable copyright laws and intellectual property rights of content owners. Any unauthorized reproduction, distribution, or commercial use of the content displayed on this platform is strictly prohibited.